These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 21109069

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Assessment of topical microbicides to prevent HIV-1 transmission: concepts, testing, lessons learned.
    Friend DR, Kiser PF.
    Antiviral Res; 2013 Sep; 99(3):391-400. PubMed ID: 23845918
    [Abstract] [Full Text] [Related]

  • 26. Antiviral and immunological effects of tenofovir microbicide in vaginal herpes simplex virus 2 infection.
    Vibholm L, Reinert LS, Søgaard OS, Paludan SR, Østergaard L, Tolstrup M, Melchjorsen J.
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1404-11. PubMed ID: 22867119
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. PHI-443: a novel noncontraceptive broad-spectrum anti-human immunodeficiency virus microbicide.
    D'Cruz OJ, Samuel P, Uckun FM.
    Biol Reprod; 2004 Dec; 71(6):2037-47. PubMed ID: 15306558
    [Abstract] [Full Text] [Related]

  • 30. Nano-microbicides: challenges in drug delivery, patient ethics and intellectual property in the war against HIV/AIDS.
    du Toit LC, Pillay V, Choonara YE.
    Adv Drug Deliv Rev; 2010 Mar 18; 62(4-5):532-46. PubMed ID: 19922751
    [Abstract] [Full Text] [Related]

  • 31. Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir.
    Akil A, Devlin B, Cost M, Rohan LC.
    Mol Pharm; 2014 May 05; 11(5):1533-41. PubMed ID: 24693866
    [Abstract] [Full Text] [Related]

  • 32. Microbicides for multidrug-resistant and multitropic HIV-1.
    D'Cruz OJ, Uckun FM.
    Curr Opin Investig Drugs; 2008 Feb 05; 9(2):152-69. PubMed ID: 18246518
    [Abstract] [Full Text] [Related]

  • 33. PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial.
    Keller MJ, Zerhouni-Layachi B, Cheshenko N, John M, Hogarty K, Kasowitz A, Goldberg CL, Wallenstein S, Profy AT, Klotman ME, Herold BC.
    J Infect Dis; 2006 Jan 01; 193(1):27-35. PubMed ID: 16323128
    [Abstract] [Full Text] [Related]

  • 34. Inhibiting sexual transmission of HIV-1 infection.
    Shattock RJ, Moore JP.
    Nat Rev Microbiol; 2003 Oct 01; 1(1):25-34. PubMed ID: 15040177
    [Abstract] [Full Text] [Related]

  • 35. Development of dapivirine vaginal ring for HIV prevention.
    Devlin B, Nuttall J, Wilder S, Woodsong C, Rosenberg Z.
    Antiviral Res; 2013 Dec 01; 100 Suppl():S3-8. PubMed ID: 24188702
    [Abstract] [Full Text] [Related]

  • 36. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1.
    Grammen C, Ariën KK, Venkatraj M, Joossens J, Van der Veken P, Heeres J, Lewi PJ, Haenen S, Augustyns K, Vanham G, Augustijns P, Brouwers J.
    Antiviral Res; 2014 Jan 01; 101():113-21. PubMed ID: 24269474
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Vaginal microbicides to prevent human immunodeficiency virus infection in women: perspectives on the female genital tract, sexual maturity and mucosal inflammation.
    Roberts L, Liebenberg L, Barnabas S, Passmore JA.
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug 01; 26(4):441-9. PubMed ID: 22429786
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.